Ameriprise’s METLIFE INC PFD SERIES B MET.PRB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-21,286
Closed -$532K 4163
2015
Q2
$532K Sell
21,286
-390
-2% -$10.1K ﹤0.01% 3411
2015
Q1
$562K Buy
21,676
+128
+0.6% +$3.34K ﹤0.01% 3158
2014
Q4
$556K Sell
21,548
-229
-1% -$5.88K ﹤0.01% 3080
2014
Q3
$558K Sell
21,777
-1,478
-6% -$37.7K ﹤0.01% 3010
2014
Q2
$594K Sell
23,255
-379
-2% -$9.63K ﹤0.01% 2938
2014
Q1
$594K Buy
23,634
+7,471
+46% +$187K ﹤0.01% 2904
2013
Q4
$402K Buy
16,163
+13,443
+494% +$333K ﹤0.01% 2931
2013
Q3
$68K Sell
2,720
-628
-19% -$15.6K ﹤0.01% 3654
2013
Q2
$85K Buy
+3,348
New +$85.4K ﹤0.01% 3449

Other funds holding MET.PRB

Ameriprise's MET.PRB Position: Q3 2015 in Review

Ameriprise sold out of METLIFE INC PFD SERIES B (MET.PRB) in Q3 2015, closing a stake of 21,286 shares — an estimated $532K sold.

Ameriprise first reported a position in MET.PRB in Q2 2013 and held it in 9 quarters. The position peaked at $594K in Q2 2014. 1 fund tracked by Wall St. Rank holds MET.PRB as of Q3 2015.

  • Ameriprise reported no remaining METLIFE INC PFD SERIES B position as of Q3 2015 after selling out during the quarter.
  • Ameriprise sold 21,286 METLIFE INC PFD SERIES B shares in Q3 2015, an estimated $532K.
  • Ameriprise first reported a position in METLIFE INC PFD SERIES B in Q2 2013 and held it in 9 quarters.
  • Ameriprise's METLIFE INC PFD SERIES B position peaked at $594K in Q2 2014.
  • 1 fund tracked by Wall St. Rank held METLIFE INC PFD SERIES B as of Q3 2015.

Based on Ameriprise's 13F filing for Q3 2015, filed 12 Nov 2015.